Publication:

Use of PD-1, CD1a, and S-100 in Differentiating Pseudolymphomatous Folliculitis and Indolent Primary Cutaneous B-Cell Lymphomas

Loading...
Thumbnail Image

Date

2015-05-13

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Goyal, Amrita. 2015. Use of PD-1, CD1a, and S-100 in Differentiating Pseudolymphomatous Folliculitis and Indolent Primary Cutaneous B-Cell Lymphomas. Doctoral dissertation, Harvard Medical School.

Abstract

Background: Pseudolymphomatous folliculitis (PLF) is a non-neoplastic lymphoid proliferation that clinically and histopathologically mimics primary cutaneous extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In this study we assessed the diagnostic value of three immunohistochemical markers, PD-1, CD1a, and S100.

Methods: We evaluated 25 cases of cutaneous lymphoid proliferations with established diagnoses, including 9 patients with PLF, 11 with MALT lymphoma, and 5 with cutaneous lymphoid hyperplasia. The clinical, histopathologic, and immunohistochemical characteristics were reviewed and three major characteristics assessed: 1) proportion of T cells expressing PD-1, 2) pattern of expression of CD1a by dendritic cells, and 3) pattern of expression of S100 by dendritic cells.

Results: We found PLF to have a significant increase in PD-1+ T cells compared to MALT lymphoma (p<0.0001). The pattern of CD1a staining is also informative: MALT lymphoma is significantly more likely to demonstrate a peripheral concentration of CD1a+ dendritic cells around lymphoid nodules than PLF (p<0.0003) or CLH (p<0.05). PLF demonstrates an interstitial distribution of CD1a+ cells more often than MALT lymphoma (p<0.04). S100 staining was not a helpful discriminator.

Conclusions: Histopathological factors including PD-1 and CD1a staining patterns may allow for more certainty in distinguishing PLF from MALT lymphoma.

Description

Other Available Sources

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories